Patents - Global Data - Dimensions
Grant
Tolerogenic DNA vaccine
Applicants
- Novo Nordisk (Denmark)
[NORA names: Novo Nordisk; Private Research; Denmark; Europe, EU; Nordic; OECD]
Abstract
The present invention relates to plasmids encoding insulin antigens and cytokines for tolerating immunity, in particular for preventing and/or delaying e.g. type 1 diabetes.
Patent Family Records (41)
Tolerogenic DNA vaccine
Novo Nordisk (Denmark), Novo Nordisk AS J. CHAPLIN, M. Villaranacura
2024, CN-118086388-A
Tolerogenic DNA vaccine
Novo Nordisk (Denmark), Novo Nordisk AS J. CHAPLIN, M. Villaranacura
2024, CN-109922827-B
Plasmid regulatory system based on temperature
Novo Nordisk (Denmark), Novo Nordisk AS J. CHAPLIN
2024, CN-109890967-B
Tolerogenic DNA vaccine
Novo Nordisk (Denmark), Novo Nordisk AS CHAPLIN JAY, WIJARANAKULA MICHAEL
2024, AU-2017353323-B2
Tolerogenic DNA Vaccine
NOVO NORDISK AS, Novo Nordisk (Denmark) JAY CHAPLIN, MICHAEL WIJARANAKULA
2023, SA-519401615-B1
Temperature based plasmid regulation system
Novo Nordisk (Denmark), Novo Nordisk AS CHAPLIN JAY
2022, US-11466278-B2
TOLEROGENIC DNA VACCINE
NOVO NORDISK AS, Novo Nordisk (Denmark) CHAPLIN JAY, WIJARANAKULA MICHAEL
2022, MY-190102-A
Tolerogenic DNA Vaccine
노보 노르디스크 에이/에스 ВИДЖАРАНАКУЛА, Майкл, ЧАПЛИН, Джей, ジェイ・チャップリン, (...more)
2022, KR-102476552-B1
Temperature-based plasmid regulation system
Novo Nordisk (Denmark), Novo Nordisk AS ВИДЖАРАНАКУЛА, Майкл, ЧАПЛИН, Джей, ジェイ・チャップリン, (...more)
2022, JP-7084388-B2
Tolerogenic dna vaccine
NOVO NORDISK AS, Novo Nordisk (Denmark)
2022, IL-266237-B
TOLEROGENIC DNA VACCINE
NOVO NORDISK A/S, Novo Nordisk (Denmark) CHAPLIN DZHEJ, VIDZHARANAKULA MAJKL
2021, RU-2752608-C2
TOLEROGENIC DNA VACCINE
NOVO NORDISK AS, Novo Nordisk (Denmark) CHAPLIN JAY, WIJARANAKULA MICHAEL
2021, PL-3534936-T3
TOLEROGENIC DNA VACCINE
NOVO NORDISK AS, Novo Nordisk (Denmark) CHAPLIN JAY, WIJARANAKULA MICHAEL
2021, HU-E051766-T2
Tolerogenic DNA vaccine
Novo Nordisk (Denmark), Novo Nordisk AS CHAPLIN JAY, WIJARANAKULA MICHAEL
2021, ES-2834329-T3
Temperature-based plasmid regulation system
Novo Nordisk (Denmark), Novo Nordisk AS CHAPLIN JAY
2021, ES-2829574-T3
TOLEROGENIC DNA VACCINE
Novo Nordisk (Denmark), Novo Nordisk AS CHAPLIN JAY, WIJARANAKULA MICHAEL
2021, EP-3799882-A1
TOLEROGENIC DNA VACCINE
NOVO NORDISK AS, Novo Nordisk (Denmark) CHAPLIN JAY, WIJARANAKULA MICHAEL
2020, SI-3534936-T1
TOLEROGENIC DNA VACCINE
Novo Nordisk (Denmark), НОВО НОРДИСК А/С ВИДЖАРАНАКУЛА, Майкл, ЧАПЛИН, Джей, ジェイ・チャップリン, (...more)
2020, RU-2019115540-A
TOLEROGENIC DNA VACCINE
NOVO NORDISK AS, Novo Nordisk (Denmark) CHAPLIN JAY, WIJARANAKULA MICHAEL
2020, RS-61138-B1
Tolerogenic DNA vaccine
Novo Nordisk (Denmark), Novo Nordisk AS ВИДЖАРАНАКУЛА, Майкл, ЧАПЛИН, Джей, ジェイ・チャップリン, (...more)
2020, JP-6721790-B2
TOLEROGENIC DNA VACCINE
Novo Nordisk (Denmark), Novo Nordisk AS JAY CHAPLIN, MICHAEL WIJARANAKULA
2020, JP-2020062057-A
TOLEROGENIC DNA VACCINE
NOVO NORDISK AS, Novo Nordisk (Denmark) CHAPLIN JAY, WIJARANAKULA MICHAEL
2020, HR-P20201710-T1
TEMPERATURE BASED PLASMID REGULATION SYSTEM
Novo Nordisk (Denmark), Novo Nordisk AS CHAPLIN JAY
2020, EP-3535399-B1
TOLEROGENIC DNA VACCINE
Novo Nordisk (Denmark), Novo Nordisk AS CHAPLIN JAY, WIJARANAKULA MICHAEL
2020, EP-3534936-B1
TOLEROGEN DNA VACCINE
NOVO NORDISK AS, Novo Nordisk (Denmark) CHAPLIN JAY, WIJARANAKULA MICHAEL
2020, DK-3534936-T3
TEMPERATURE BASED PLASMID REGULATION SYSTEM
Novo Nordisk (Denmark), Novo Nordisk AS CHAPLIN JAY
2019, US-20190241898-A1
TOLEROGENIC DNA VACCINE
NOVO NORDISK AS, Novo Nordisk (Denmark) CHAPLIN JAY, WIJARANAKULA MICHAEL
2019, PH-12019500851-A1
TOLEROGENIC DNA VACCINE
NOVO NORDISK AS, Novo Nordisk (Denmark) CHAPLIN JAY, WIJARANAKULA MICHAEL
2019, PE-20190841-A1
TOLEROGENIC DNA VACCINE.
NOVO NORDISK AS, Novo Nordisk (Denmark) JAY CHAPLIN, MICHAEL WIJARANAKULA
2019, MX-2019004774-A
An idiotatic DNA vaccine
NOVO NORDISK A, Novo Nordisk (Denmark) CHAPLIN JAY, WIJARANAKULA MICHAEL
2019, KR-20190076020-A
Temperature-based plasmid regulatory system
Novo Nordisk (Denmark), Novo Nordisk AS ВИДЖАРАНАКУЛА, Майкл, ЧАПЛИН, Джей, ジェイ・チャップリン, (...more)
2019, JP-2019532660-A
Tolerance-inducing DNA vaccine
Novo Nordisk (Denmark), Novo Nordisk AS ВИДЖАРАНАКУЛА, Майкл, ЧАПЛИН, Джей, ジェイ・チャップリン, (...more)
2019, JP-2019532659-A
TEMPERATURE BASED PLASMID REGULATION SYSTEM
Novo Nordisk (Denmark), Novo Nordisk AS CHAPLIN JAY
2019, EP-3535399-A1
TOLEROGENIC DNA VACCINE
Novo Nordisk (Denmark), Novo Nordisk AS CHAPLIN JAY, WIJARANAKULA MICHAEL
2019, EP-3534936-A1
Tolerant DNA vaccine
NOVO NORDISK AS, Novo Nordisk (Denmark) CHAPLIN JAY, WIJARANAKULA MICHAEL
2019, CO-2019004193-A2
Tolerogenesis DNA vaccination
Novo Nordisk (Denmark), Novo Nordisk AS CHAPLIN JAY, WIJARANAKULA MICHAEL
2019, CN-109922827-A
Plasmid regulating system based on temperature
Novo Nordisk (Denmark), Novo Nordisk AS CHAPLIN JAY
2019, CN-109890967-A
Vaccine of tolerogenic DNA.
NOVO NORDISK AS, Novo Nordisk (Denmark) CHAPLIN JAY, WIJARANAKULA MICHAEL
2019, CL-2019001181-A1
tolerogenic DNA vaccine
NOVO NORDISK AS, Novo Nordisk (Denmark) JAY CHAPLIN, MICHAEL WIJARANAKULA
2019, BR-112019007408-A2
Tolerogenic DNA vaccine
Novo Nordisk (Denmark), Novo Nordisk AS CHAPLIN JAY, WIJARANAKULA MICHAEL
2019, AU-2017353323-A1
TOLEROGENIC DNA VACCINE
Novo Nordisk (Denmark), Novo Nordisk AS CHAPLIN JAY, WIJARANAKULA MICHAEL
2018, CA-3042321-A1